NAD+, NMN & NR: The Longevity Hype, Fact-Checked

NAD+ (nicotinamide adenine dinucleotide) sits in every cell and participates in hundreds of reactions — energy production, DNA repair, cellular ageing pathways. That levels fall with age made it the perfect longevity candidate: a measurable marker, a plausible story, and in NMN and NR two precursors that can be sold as capsules. In mouse models, topping NAD up delivered impressive headlines — better metabolic values, more endurance, signs of slowed ageing.

The catch is the eternal one: mice are not humans, and anti-ageing research history is a graveyard of substances that shone in animal models. Which is why the human data is what counts — and that reading is short.

Safety and NAD elevation: the NR study by Martens and colleagues (healthy middle-aged and older adults, weeks of supplementation) showed good tolerability and roughly 60% higher blood NAD levels — but no consistently significant improvements over placebo on the clinically interesting endpoints (including vascular function and blood pressure).

The insulin finding — and what became of it: Yoshino and colleagues gave prediabetic, overweight women NMN for ten weeks: skeletal muscle insulin sensitivity measurably improved — a genuine, publication-worthy finding. Equally honest: it was a small trial (25 participants) in a specific group, and practically all other measured outcomes (weight, long-term glucose markers, blood lipids, blood pressure) remained unchanged. A 2024 meta-analysis of eight randomised trials (n=342) has since delivered the pooled picture: no effect of NMN on glucose, insulin, HbA1c or blood lipids. The single 2021 finding did not hold up — exactly the pattern typical of longevity hype once a small signal meets a larger evidence base.

Muscle and strength in older age: a 2025 systematic review in older adults (61–83 years) tested precisely the endpoints the marketing promises — and found: NMN/NR improved neither muscle mass, nor grip strength, nor gait speed. Anyone hoping NAD boosters bring more strength in old age gets none, according to the current evidence.

What is completely missing: long-term data (trials run weeks to a few months), hard endpoints (disease, function in old age, mortality) and independent replication at relevant scale. For a product marketed as a decades-long investment in ageing, that is a remarkably thin file.

In the EU, NMN preparations count as novel foods — and NMN does not hold that authorisation. The consequence: regular sale as a food supplement is not permitted; what circulates anyway via international online shops bypasses the European control framework for safety, purity and labelling. Independent product tests in recent years have additionally found repeated, substantial deviations between declared and actual content in NMN products. NR, by contrast, is authorised as a novel food (with defined amounts and conditions) — but sits in the same thin evidence for actual benefit.

Then the price question: longevity protocols with NMN/NR quickly cost a three-digit sum per month — year after year, for an unproven effect. Consequently, we link no products in this article.

The uncomfortably banal punchline of NAD research: the best-documented "NAD boosters" are free. Training — especially the combination of strength and easy endurance — activates the cellular energy sensors the NAD metabolism serves, and remains the only intervention with proven effects on practically every ageing endpoint people actually care about: strength, endurance, bone density, metabolism, fall risk. Add sleep, not smoking, moderate alcohol, sufficient protein. If your foundation stands and you still want to experiment, do it clear-eyed: as an experiment at your own expense, not an evidence-based investment — and with medication or pre-existing conditions only after medical consultation.